Systolic heart failure: practical implementation of standard guidelines.
Congestive heart failure (CHF) is being described as an epidemic of the next decade. Despite significant advances in the treatment of systolic heart failure, community mortality remains high, which is partly due to a failure to implement standard guidelines. The purpose of this article is to describe the scope of the problem, advances in pathophysiology, common clinical scenarios, and practical implementation of standard therapies for CHF.
Pereira
N L
NL
Division of Cardiology, Gazes Cardiac Research Institute, Medical University of South Carolina, Charleston, South Carolina, USA.
Cooper
G
G
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use; D001835:Body Weight; D002311:Cardiomyopathy, Dilated / Q000473:pathology; D006333:Heart Failure / Q000150:complications / Q000175:diagnosis / Q000188:drug therapy* / Q000503:physiopathology; D006339:Heart Rate; D006760:Hospitalization; D006801:Humans; D009206:Myocardium / Q000473:pathology; D018487:Ventricular Dysfunction, Left / Q000150:complications / Q000503:physiopathology
D000319:Adrenergic beta-Antagonists; D000806:Angiotensin-Converting Enzyme Inhibitors